After mutation of the complementary sites of miR-491-5p to LBX2-AS1, relative luciferase activity was unable to be affected by miR-491-5p, confirming the specific interaction between LBX2-AS1 and miR-491-5p in glioma cells (Figure 5E). This evidence concerns the gene LBX2 and central nervous system cancer.